# SUCRALFATE
> **ANDA212913** · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN · Approved 2022-09-12
## Drug
- **FDA Application Number:** ANDA212913
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SUCRALFATE
- **Generic name:** SUCRALFATE
- **Active ingredients:** SUCRALFATE
- **Dosage form:** SUSPENSION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** MYLAN
- **Manufacturer:** Mylan Pharmaceuticals Inc.
- **First approval:** 2022-09-12
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212913)
---
*MORVS · CC0 1.0*